Brazilian Journal of Anesthesiology
https://bjan-sba.org/article/doi/10.1016/j.bjane.2017.06.002
Brazilian Journal of Anesthesiology
Review Article

Evaluation and perioperative management of patients with diabetes mellitus. A challenge for the anesthesiologist

Avaliação e manejo perioperatório de pacientes com diabetes melito. Um desafio para o anestesiologista

João Paulo Jordão Pontes; Florentino Fernandes Mendes; Mateus Meira Vasconcelos; Nubia Rodrigues Batista

Downloads: 2
Views: 1038

Abstract

Abstract Diabetes mellitus (DM) is characterized by alteration in carbohydrate metabolism, leading to hyperglycemia and increased perioperative morbidity and mortality. It evolves with diverse and progressive physiological changes, and the anesthetic management requires attention regarding this disease interference in multiple organ systems and their respective complications. Patient's history, physical examination, and complementary exams are important in the preoperative management, particularly glycosylated hemoglobin (HbA1c), which has a strong predictive value for complications associated with diabetes. The goal of surgical planning is to reduce the fasting time and maintain the patient's routine. Patients with Type 1 DM must receive insulin (even during the preoperative fast) to meet the basal physiological demands and avoid ketoacidosis. Whereas patients with Type 2 DM treated with multiple injectable and/or oral drugs are susceptible to develop a hyperglycemic hyperosmolar state (HHS). Therefore, the management of hypoglycemic agents and different types of insulin is fundamental, as well as determining the surgical schedule and, consequently, the number of lost meals for dose adjustment and drug suspension. Current evidence suggests the safe target to maintain glycemic control in surgical patients, but does not conclude whether it should be obtained with either moderate or severe glycemic control.

Keywords

Diabetes mellitus, Anesthesia, Perioperative care, Hypoglycemic agents, Insulin, Glycosylated hemoglobin

Resumo

Resumo O diabetes melito (DM) é caracterizado por alteração no metabolismo de carboidratos que leva à hiperglicemia e ao aumento da morbimortalidade perioperatória. Cursa com alterações fisiológicas diversas e progressivas e, para o manejo anestésico, deve-se atentar para a interferência dessa doença nos múltiplos sistemas orgânicos e suas respectivas complicações. Anamnese, exame físico e exames complementares são importantes no manejo pré-operatório, com destaque para a hemoglobina glicosilada (HbA1c), que tem forte valor preditivo para complicações associadas ao diabetes. O planejamento cirúrgico tem como objetivos a redução do tempo de jejum e a manutenção da rotina do paciente. Pacientes portadores de DM Tipo 1 precisam receber, mesmo em jejum perioperatório, insulina para suprir as demandas fisiológicas basais e evitar cetoacidose. Já os pacientes portadores de DM Tipo 2, tratados com múltiplos fármacos injetáveis e/ou orais, são suscetíveis ao desenvolvimento de um estado hiperosmolar hiperglicêmico (EHH). Assim, o manejo dos hipoglicemiantes e dos diferentes tipos de insulina é fundamental, além da determinação do horário cirúrgico e, consequentemente, do número de refeições perdidas para adequação de doses ou suspensão dos medicamentos. As evidências atuais sugerem o alvo de manutenção da glicemia seguro para os pacientes cirúrgicos, sem concluir se deve ser obtido com controle glicêmico intensivo ou moderado.

Palavras-chave

Diabetes melito, Anestesia, Cuidados perioperatórios, Hipoglicemiantes, Insulina, Hemoglobina glicosilada

References

Frisch A, Chandra P, Smiley D. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care. 2010;33:1783-8.

Barker P, Creasey PE, Dhatariya K. Peri-operative management of the surgical patient with diabetes 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia. 2015;70:1427-40.

Stumvall M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365:1333-46.

Standards of medical care in diabetes - 2015. Classification and diagnosis of diabetes. Diabetes Care. 2015;38(Suppl. 1):S8-S16.

Sebranek JJ, Lugli AK, Coursin DB. Glycaemic control in the perioperative period. Br J Anaesth. 2013;111(Suppl. 1):i18-34.

Larkin ME, Barnie A, Braffett BH. Musculoskeletal complications in type 1 diabetes. Diabetes Care. 2014;37:1863-9.

Wall R. Endocrine disease. Stoelting's anesthesia and co-existing disease. 2012:376-84.

Soldevila B, Lucas AM, Zavala R. Perioperative management of the diabetic patient. Perioperative medicine - current controversies. 2016:165-92.

Perazella MA, Tray K. Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs. Am J Med. 2001;111:64.

Moitra VK, Meiler SE. The diabetic surgical patient. Curr Opin Anaesthesiol. 2006;19:339-45.

Selvin E, Coresh J, Shahar E. Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Lancet Neurol. 2005;4:821-6.

Kadoi Y, Hinohara H, Kunimoto F. Diabetic patients have an impaired cerebral vasodilatory response to hypercapnia under propfol anesthesia. Stroke. 2003;34:2399-403.

Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis. JAMA. 2002;287:2570-81.

Haffner SM, Lehto S, Ronnemaa T. Mortality from coronary artery disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-34.

Evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.

Fleisher LA, Fleischmann KE, Auerbach AD. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:2215-45.

Joshi GP, Chung F, Vann MA. Society for ambulatory anaesthesia consensus statement on perioperative blood glucose management in diabetic patients undergoing ambulatory surgery. Anesth Analg. 2010;111:1378-87.

Loh-Trivedi M, Croley WC. Perioperative management of the diabetic patient. 2015.

Abdelmalak B, Abdelmalak JB, Knittel J. The prevalence of undiagnosed diabetes in non-cardiac surgery patients, an observational study. Can J Anaesth. 2010;57:1058-64.

Sheehy AM, Benca J, Glinberg SL. Preoperative ‘NPO' as an opportunity for diabetes screening. J Hosp Med. 2012;7:611-66.

Lauruschkat AH, Arnrich B, Albert AA. Prevalence and risks of undiagnosed diabetes mellitus in patients undergoing coronary artery bypass grafting. Circulation. 2005;112:2397-402.

Kadoi Y. Anaesthetic considerations in diabetic patients. Part I: preoperative considerations of patients with diabetes mellitus. J Anesth. 2010;24:739-47.

Khan NA, Ghali WA, Cagliero E. Perioperative management of blood glucose in adults with diabetes mellitus. 2016.

Standards of medical care in diabetes - 2015. Diabetes Care. 2015;38(Suppl. 1):S33-40.

Wei N, Zheng H, Nathan DM. Empirically establishing blood glucose targets to achieve HbA1c goals. Diabetes Care. 2014;37:1048-51.

Nathan DM, Kuenen J, Borg R. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31:1473-8.

Walid MS, Newman BF, Yelverton JC. Prevalence of previously unknown elevation of glycosylated hemoglobin in spine surgery patients and impact on length of stay and total cost. J Hosp Med. 2010;5:10-4.

O'Sullivan CJ, Hynes N, Mahendran B. Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome?. Eur J Vasc Endovasc Surg. 2006;32:188-97.

Gustafsson UO, Thorell A, Soop M. Haemoglobin A1c as a predictor of postoperative hyperglycaemia and complications after major colorectal surgery. Br J Surg. 2009;96:1358-64.

Halkos ME, Lattouf OM, Puskas JD. Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery. Ann Thorac Surg. 2008;86:1431-7.

Alserius T, Anderson RE, Hammar N. Elevated glycosylated haemoglobin (HbA1c) is a risk marker in coronary artery bypass surgery. Scand Cardiovasc J. 2008;42:392-8.

Kreutziger J, Schlaepfer J, Wenzel V. The role of admission blood glucose in outcome prediction of surviving patients with multiple injuries. J Trauma. 2009;67:704-8.

Vilar-Compte D, Alvarez de Iturbe I, Martin-Onraet A. Hyperglycemia as a risk factor for surgical site infections in patients undergoing mastectomy. Am J Infect Control. 2008;36:192-8.

Shibuya N, Humphers JM, Fluhman BL. Factors associated with nonunion, delayed union, and malunion in foot and ankle surgery in diabetic patients. J Foot Ankle Surg. 2013;52:207-11.

Chuang SC, Lee KT, Chang WT. Risk factors for wound infection after cholecystectomy. J Formos Med Assoc. 2004;103:607-12.

Ambiru S, Kato A, Kimura F. Poor postoperative blood glucose control increases surgical site infections after surgery for hepato-biliary-pancreatic cancer: a prospective study in a high-volume institute in Japan. J Hosp Infect. 2008;68:230-3.

Underwood P, Askari R, Hurwitz S. Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures. Diabetes Care. 2014;37:611-6.

Preoperative tests (update): routine preoperative tests for elective surgery. 2016.

Aldam P, Levy N, Hall GM. Perioperative management of diabetic patients: new controversies. Br J Anaesth. 2014;113:906-9.

Kwon S, Thompson R, Dellinger P. Importance of perioperative glycemic control in general surgery: a report from the surgical care and outcomes assessment program. Ann Surg. 2013;257:8-14.

Bock M, Johansson T, Fritsch G. The impact of preoperative testing for blood glucose concentration and haemoglobin A1c on mortality, changes in management and complications in noncardiac elective surgery: a systematic review. Eur J Anaesthesiol. 2015;32:152-9.

Akhtar S, Barash PG, Inzucchi SE. Scientific principles and clinical implications of perioperative glucose regulation and control. Anesth Analg. 2010;110:478-97.

Bagry HS, Raghavendran S, Carli F. Metabolic syndrome and insulin resistance: perioperative considerations. Anesthesiology. 2008;108:506-23.

McAnulty GR, Robertshaw HJ, Hall GM. Anaesthetic management of patients with diabetes mellitus. Br J Anaesth. 2000;85:80-90.

Fragen RJ, Shanks CA, Molteni A. Effects of etomidate on hormonal responses to surgical stress. Anesthesiology. 1984;61:652-6.

Belhoula M, Ciébiéra JP, De La Chapelle A. Clonidine premedication improves metabolic control in type 2 diabetic patients during ophthalmic surgery. Br J Anaesth. 2003;90:434-9.

Lattermann RT, Schricker U, Wachter M. Understanding the mechanisms by which isoflurane modifies the hyperglycemic response to surgery. Anesth Analg. 2001;93:121-7.

Halter JB, Pflug AE. Effect of sympathetic blockade by spinal anaesthesia on pancreatic islet function in man. Am J Physiol. 1980;239:150-5.

Donatelli F, Vavassori A, Bonfanti S. Epidural anaesthesia and analgesia decrease the postoperative incidence of insulin resistance in preoperative insulin-resistant subjects only. Anesth Analg. 2007;104:1587-93.

Osterman AL. The double crush syndrome. Orthop Clin N Am. 1988;19:147-55.

Kalichman MW, Calcutt NA. Local anesthetic-induced conduction block and nerve fiber injury in streptozotocin-diabetic rats. Anesthesiology. 1992;77:941-7.

Willams BA. Toward a paradigm shift for the clinical care of diabetic patients requiring perineural analgesia: strategies for using the diabetic rat model. Reg Anesth Pain Med. 2010;35:329-32.

Gebhard RE, Nielsen KC, Pietrobon R. Diabetes mellitus, independent of body mass index, is associated with a "higher success" rate for supraclavicular brachial plexus blocks. Reg Anesth Pain Med. 2009;34:404-7.

Sites BD, Gallagher J, Sparks M. Ultrasound-guided popliteal block demonstrates an atypical motor response to nerve stimulation in 2 patients with diabetes mellitus. Reg Anesth Pain Med. 2003;28:479-82.

Neal JM, Barrington MJ, Brull R. The second ASRA practice advisory on neurologic complications associated with regional anesthesia and pain medicine executive summary 2015. Reg Anesth Pain Med. 2015;40:401-30.

Duncan AI, Koch CG, Xu M. Recent metformin ingestion does not increase in-hospital morbidity or mortality after cardiac surgery. Anesth Analg. 2007;104:42-50.

Standards for intravascular contrast agent administration to adult patients. 2010.

Approach to glycemic control. Diabetes Care. 2015;38(Suppl. 1):S41-8.

Sudhakaran S, Surani SR. Guidelines for perioperative management of the diabetic patient. Surg Res Pract. 2015;2015:284063.

Dhatariya K, Levy N, Kilvert A. NHS diabetes guideline for the perioperative management of the adult patient with diabetes. Diabet Med. 2012;29:420-33.

Peri-operative diabetes management guidelines. 2012.

Ferreira VA. Avanços farmacológicos no tratamento do diabetes tipo 2. Braz J Surg Clin Res (BJSCR). 2014;8:72-8.

Vann MA. Management of diabetes medications for patients undergoing ambulatory surgery. Anesthesiol Clin. 2014;32:329-39.

Simpson AK, Levy N, Hall GM. Peri-operative i.v. fluids in diabetic patients - don't forget the salt. Anaesthesia. 2008;63:1043-5.

Moghissi ES, Korytkowski MT, Di Nardo M. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15:353-69.

Langouche L, Vanhorebeek I, Vlasselaers D. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest. 2005;115:2277-86.

Sathya B, Davis R, Taveira T. Intensity of peri-operative glycaemic control and postoperative outcomes in patients with diabetes: a meta-analysis. Diabetes Res Clin Pract. 2013;102:8-15.

Buchleitner AM, Martínez-Alonso M, Hernández M. Perioperative glycaemic control for diabetic patients undergoing surgery. Cochrane Database Syst Rev. 2012:CD007315.

5dcc5d950e88258522bf58f1 rba Articles
Links & Downloads

Braz J Anesthesiol

Share this page
Page Sections